Association between Visit-to-Visit Ultrafiltration Volume Variability, Vascular Biomarkers and Cardiovascular

Balázs Sági1,2, Tibor Vas1, Rita Klaudia Jakabfi-Csepregi3,4

  • 12nd Department of Internal Medicine and Nephrology, Diabetes Center, Clinical Center, Medical School, University of Pécs, Pacsirta Street 1, 7624 Pécs, Hungary.

PubMed

Insights

High visit-to-visit ultrafiltration variability in hemodialysis patients is linked to worse cardiovascular health, including increased left ventricular hypertrophy and reduced ejection fraction. This suggests a higher cardiovascular risk in these patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular diseases are a leading cause of death in hemodialysis patients.
  • Ultrafiltration (UF) variability may contribute to cardiovascular complications.
  • Understanding UF's impact is crucial for managing hemodialysis patient health.

Purpose of the Study:

  • To investigate the association between visit-to-visit ultrafiltration volume variability (UVSD) and cardiovascular abnormalities in hemodialysis patients.
  • To assess the impact of high UVSD on arterial stiffness, cardiac structure, and function.

Main Methods:

  • Twenty-nine hemodialysis patients were studied.
  • Visit-to-visit ultrafiltration volume variability (UVSD) was calculated over 12 months.
  • Measurements included plasma markers (SDC-1, ET-1), applanation tonometry (cfPWV), echocardiography (LVEDD, LVMI, LVEF), and blood pressure.

Main Results:

  • High UVSD group showed lower pre-HD cfPWV but increased post-HD cfPWV, indicating more elastic arteries.
  • Higher left ventricular end-diastolic diameter (LVEDD) and left ventricular mass index (LVMI) were observed in the high UVSD group.
  • Reduced left ventricular ejection fraction (LVEF) and lower pre-HD endothelin-1 (ET-1) levels were found in patients with high UVSD.

Conclusions:

  • High UVSD is associated with left ventricular hypertrophy and dysfunction in hemodialysis patients.
  • Despite similar fluid removal, high UVSD correlates with adverse cardiac remodeling and reduced LVEF.
  • These findings suggest that high UF variability may increase cardiovascular risk in hemodialysis patients.

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
2
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
2
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
2